Societal CDMO, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCTL research report →
Companywww.societalcdmo.com
Societal CDMO, Inc. , a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.
- CEO
- J. David Enloe Jr.
- IPO
- 2014
- Employees
- 258
- HQ
- Exton, PA, US
Price Chart
Valuation
- Market Cap
- $116.13M
- P/E
- -7.89
- P/S
- 1.23
- P/B
- 1.79
- EV/EBITDA
- 26.49
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 19.54%
- Op Margin
- -1.86%
- Net Margin
- -14.03%
- ROE
- -22.40%
- ROIC
- -1.24%
Growth & Income
- Revenue
- $94.64M · 4.90%
- Net Income
- $-13,274,000 · 33.23%
- EPS
- $-0.14 · 58.82%
- Op Income
- $-1,759,000
- FCF YoY
- 3.50%
Performance & Tape
- 52W High
- $1.28
- 52W Low
- $0.26
- 50D MA
- $0.78
- 200D MA
- $0.61
- Beta
- 1.58
- Avg Volume
- 998.39K
Get TickerSpark's AI analysis on SCTL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 8, 24 | Arens Mathew Paul | sell | 1,250,000 |
| Apr 8, 24 | Arens Mathew Paul | sell | 20,000 |
| Apr 8, 24 | Arens Mathew Paul | other | 19,676,396 |
| Apr 8, 24 | Weisman Wayne | other | 234,982 |
| Apr 8, 24 | Weisman Wayne | sell | 73,620 |
| Apr 8, 24 | Weisman Wayne | sell | 118,182 |
| Apr 8, 24 | Weisman Wayne | sell | 27,229 |
| Apr 8, 24 | Reasons Bryan M. | other | 217,429 |
| Apr 8, 24 | Reasons Bryan M. | sell | 118,182 |
| Apr 8, 24 | Reasons Bryan M. | sell | 27,229 |
Our SCTL Coverage
We haven't published any research on SCTL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SCTL Report →